United States · 
Who invested in ImmuneXcite?
ImmuneXcite's investors include Massachusetts Life Sciences Center.
201220132014
$2.5MSeries A$3.6MSeries BUnited States · Series B startup
Who invested in ImmuneXcite
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$6.1Mraised across 2 rounds since 2012, from 2 sources
$2.5MSeries A$3.6MSeries B
- Latest round
- Series B, $3.6MJan 2014
- Step-upi
- 1.4×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $2.5M Jan 2012
- Biggest round
- $3.6M Series B · Jan 2014
- Between rounds
- 2 years from the last two
The rounds
- Jan 2014Series B$3.6M1 new
From a historical funding recordSEC filing: $3.6M sold, first sale Dec 2013
- Jan 2012Series A$2.5M
No investor was named in the report.
Reported by masshightech.comSEC filing: $2.4M sold, first sale Dec 2011
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about ImmuneXcite
How much has ImmuneXcite raised?
ImmuneXcite has raised $6.1M across 2 rounds since 2012.
When did ImmuneXcite last raise?
ImmuneXcite's most recent round was a Series B of $3.6M in Jan 2014.
What was ImmuneXcite's biggest round?
Its most recent round, $3.6M in Jan 2014, is also its largest on record.
Who backed ImmuneXcite first?
ImmuneXcite's first round on record, in Jan 2014, was backed by Massachusetts Life Sciences Center.
What stage is ImmuneXcite at?
ImmuneXcite's latest named round is a Series B, in Jan 2014.
Where is ImmuneXcite based?
ImmuneXcite is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.